X. Rosa Ma,Stephanie D. Conley,Michael Kosicki,Danila Bredikhin,Ran Cui,Steven Tran,Maya U. Sheth,Wei-Lin Qiu,Sijie Chen,Soumya Kundu,Helen Y. Kang,Dulguun Amgalan,Chad J. Munger,Lauren Duan,Katherine Dang,Oriane Matthys Rubio,Shinwan Kany,Siavash Zamirpour,John DePaolo,Arun Padmanabhan,Birth Defects Research Laboratory,Jeffrey Olgin,Scott Damrauer,Robin Andersson,Mingxia Gu,James R. Priest,Thomas Quertermous,Xiaojie Qiu,Marlene Rabinovitch,Axel Visel,Len Pennacchio,Anshul Kundaje,Ian A. Glass,Casey A. Gifford,James P. Pirruccello,William R. Goodyer,Jesse M. Engreitz

Abstract:Congenital heart defects (CHD) arise in part due to inherited genetic variants that alter genes and noncoding regulatory elements in the human genome. These variants are thought to act during fetal development to influence the formation of different heart structures. However, identifying the genes, pathways, and cell types that mediate these effects has been challenging due to the immense diversity of cell types involved in heart development as well as the superimposed complexities of interpreting noncoding sequences. As such, understanding the molecular functions of both noncoding and coding variants remains paramount to our fundamental understanding of cardiac development and CHD. Here, we created a gene regulation map of the healthy human fetal heart across developmental time, and applied it to interpret the functions of variants associated with CHD and quantitative cardiac traits. We collected single-cell multiomic data from 734,000 single cells sampled from 41 fetal hearts spanning post-conception weeks 6 to 22, enabling the construction of gene regulation maps in 90 cardiac cell types and states, including rare populations of cardiac conduction cells. Through an unbiased analysis of all 90 cell types, we find that both rare coding variants associated with CHD and common noncoding variants associated with valve traits converge to affect valvular interstitial cells (VICs). VICs are enriched for high expression of known CHD genes previously identified through mapping of rare coding variants. Eight CHD genes, as well as other genes in similar molecular pathways, are linked to common noncoding variants associated with other valve diseases or traits via enhancers in VICs. In addition, certain common noncoding variants impact enhancers with activities highly specific to particular subanatomic structures in the heart, illuminating how such variants can impact specific aspects of heart structure and function. Together, these results implicate new enhancers, genes, and cell types in the genetic etiology of CHD, identify molecular convergence of common noncoding and rare coding variants on VICs, and suggest a more expansive view of the cell types instrumental in genetic risk for CHD, beyond the working cardiomyocyte. This regulatory map of the human fetal heart will provide a foundational resource for understanding cardiac development, interpreting genetic variants associated with heart disease, and discovering targets for cell-type specific therapies.

Abstract 16596: Dominant Mouse Mutagenesis Screen Unveils a Complex Genetic Architecture for Congenital Heart Disease

ENU-based dominant genetic screen identifies contractile and neuronal gene mutations in congenital heart disease

Amendment history : Corrigendum ( April 2017 ) A modifier screen identifies DNAJB 6 as a cardiomyopathy susceptibility gene

Large-scale Screening of Disease Model Through ENU Mutagenesis in Mice

A Modifier Screen Identifies DNAJB6 As a Cardiomyopathy Susceptibility Gene.

Germline Saturation Mutagenesis Induces Skeletal Phenotypes in Mice

Molecular convergence of risk variants for congenital heart defects leveraging a regulatory map of the human fetal heart

Functional dissection of human cardiac enhancers and noncoding de novo variants in congenital heart disease

De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies

Integrative single-cell analysis of cardiogenesis identifies developmental trajectories and non-coding mutations in congenital heart disease

Massively Parallel Sequencing Identifies The Gene Megf8 With Enu-Induced Mutation Causing Heterotaxy

Mitotic Block and Epigenetic Repression Underlie Neurodevelopmental Defects and Neurobehavioral Deficits in Congenital Heart Disease

Knockout mice are an important tool for human monogenic heart disease studies

An update on the molecular diagnosis of congenital heart disease: focus on loss-of-function mutations

The Expression Profile Analysis of NKX2-5 Knock-out Embryonic Mice to Explore the Pathogenesis of Congenital Heart Disease.

Genetic analysis of Down syndrome-associated heart defects in mice

Mutagenesis Sensitivity Mapping of Human Enhancers In Vivo

A Machine Learning Classifier to Identify and Prioritise Genes Associated with Cardiac Development

Multiple gene variations contributed to congenital heart disease via GATA family transcriptional regulation

De Novo Mutations in Histone-Modifying Genes in Congenital Heart Disease Congenital Heart Disease Entering a New Era of Human Genetics Commentaries on Cutting Edge Science

Association of assisted reproductive technology, germline de novo mutations and congenital heart defects in a prospective birth cohort study